Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10-Reference-Cited by-同舟云学术

Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10

Published:2011-08 Issue:2 Volume:55 Page:288-293
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Antonelli Alessandro,Ferrari Silvia Martina,Frascerra Silvia,Galetta Fabio,Franzoni Ferdinando,Corrado Alda,Miccoli Mario,Benvenga Salvatore,Paolicchi Aldo,Ferrannini Ele,Fallahi Poupak

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference38 articles.

1. Human Mig chemokine: biochemical and functional characterization;Liao;J Exp Med,1995

2. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity;Romagnani;J Clin Invest,2001

3. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s;Bonecchi;J Exp Med,1998

4. 5′ regulatory region of a novel cytokine gene mediates selective activation by interferon gamma;Wright;J Exp Med,1991

5. CXCR3, inflammation, and autoimmune diseases;Lacotte;Ann NY Acad Sci,2009

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the potential of myo-inositol in thyroid disease management: focus on thyroid cancer diagnosis and therapy;Frontiers in Endocrinology;2024-09-12

2. Identification and analysis correlation between hub genes and immune cell infiltration related to LPS-induced cognitive impairment;Heliyon;2024-09

3. Genetically predicted associations between circulating cytokines and autoimmune diseases: a bidirectional two-sample Mendelian randomization;Frontiers in Immunology;2024-05-27

4. Tumor microenvironment in thyroid cancer: Immune cells, patterns, and novel treatments;Head & Neck;2024-02-21

5. Efficacy and Safety of intravenous monoclonal antibodies in patients with moderate-to-severe active Graves’ophthalmopathy: a systematic review and meta-analysis;Frontiers in Endocrinology;2023-05-23